RXRX News and Press, Recursion Pharmaceuticals Inc. From 04/16/24

SALT LAKE CITY, April 16, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery and development, announced Najat Khan, PhD, will be its Chief R&D Officer and Chief Commercial Officer. Dr. Khan ...

2024-04-10 05:50:00 ET Don't call Recursion Pharmaceuticals (NASDAQ: RXRX) a biotech company. Its management prefers the term "TechBio." While many have been skeptical about TechBio in the past, the reception is changing rapidly. There's a good reason for this shift: The tech pa...

2024-04-10 05:12:54 ET Summary Recursion Pharmaceuticals uses high-dimensional data and modern approaches to generate predictive results for drug discovery and development. The company has strengthened its tech stack through partnerships and collaborations with big players in the ...

2024-04-04 08:45:00 ET Artificial intelligence (AI) will revolutionize the way many companies do business. It could even fundamentally change entire industries. Picking the corporations driving these changes could pay off massive dividends -- literally and figuratively -- down the road. ...

SALT LAKE CITY, March 26, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery, today announced the release of its third annual Environmental, Social and Governance (ESG) Report . The repo...

2024-03-21 12:34:51 ET Summary Nvidia Corporation strategically invests in key sectors of the AI space to enhance its future capabilities and bottom line. Investments in Databricks, ARM Inc., Recursion Pharmaceuticals, and SoundHound AI have the potential to boost Nvidia's earning...

2024-03-21 11:53:17 ET More on S&P 500 Index: Chairman Powell Hits A Grand Slam Home Run Despite What The Fed Says, The Policy Is Still 'Higher-For-Longer' The Fed Is More Dovish Than The Market Anticipates 32 “Breakthroughs” stocks by BofA ...

2024-03-19 20:50:22 ET Summary Recursion Pharmaceuticals has seen a 35% increase in stock price, driven by investments from NVIDIA and Roche. Key pipeline projects target unmet needs in CCM, NF2, and Familial Adenomatous Polyposis, with significant R&D investment reported. ...

2024-03-15 10:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-13 17:07:28 ET Gainers: Turtle Beach ( HEAR ) +22% . SoundHound ( SOUN ) +12% . Robinhood Markets ( HOOD ) +9% . Recursion Pharmaceuticals ( RXRX ) +7% . Pyxis Oncology ( PYXS ) +3% . Losers: WW International ( ...